[Parkinsonism. Therapeutic, pathophysiological, pharmacological and biochemical aspects].
D000547:Amantadine / Q000494:pharmacology / Q000627:therapeutic use; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002490:Central Nervous System / Q000187:drug effects / Q000503:physiopathology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D026741:Physical Therapy Modalities; D013238:Stereotaxic Techniques
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D000547:Amantadine
Parkinsonisme. Terapeutiske, patofysiologiske, farmakologiske og biokemiske aspekter.